Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT04704986
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 202 participants
- Registry
-
NCT04704986
-
- Other papers using this trial's data
- PolarX vs Arctic Front for Cryoballoon Ablation of Paroxysmal AF: The Randomized COMPARE CRYO Study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT04704986. Randomized; no masking; primary purpose treatment. Start 2021-03-29 (actual); primary completion 2023-07-31 (actual). Results posted on 2026-07-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
- Acronym
- COMPARE-CRYO
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- PVI using the Arctic Front Cryoballoon (Medtronic)
- Intervention (Drug)
- PVI using the PolarX Cryoballoon (Boston Scientific)
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- University Hospital, Basel, Switzerland
Record details
- Record id
cardio:ct-nct04704986- Content hash
2ffbc908cdc0aa085e39f68c49fb458ca016073f2b38122c06ebe7defb8bc9c7